Series B funding round for Mersana Therapeutics raising $35M in March 2015
Series B funding round for Mersana Therapeutics raising $35M in March 2015
| Investor | Firm Type | Partner |
|---|
NEALEAD | Venture Capital | — |
| Venture Capital | — | |
| Private | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Angel | Elliott Sigal | |
| Angel | David Parkinson |
This company has completed 4 funding rounds. Current round is highlighted.
Total Raised
$110M
Top Valuation
-
Mersana Therapeutics raised $35M in a Series B round.
The round was announced on 03/01/15.
The round was led by David Mott.